Difference between revisions of "Team:ColumbiaNYC/Collaborations"

Line 50: Line 50:
 
               mediated cancer therapies, from both patients and field specialists.</td>
 
               mediated cancer therapies, from both patients and field specialists.</td>
 
           </tr>
 
           </tr>
 +
 +
        <tr>
 +
            <td class="yaxis">Stony Brook University</td>
 +
            <td>Survey</td>
 +
            <td> While new treatments can be very powerful, the ability of treatments to impact patients heavily relies on the willingness of patients to embrace them. To assess how well patients will receive the treatments developed by Columbia iGEM and Stony Brook iGEM, the two teams have joined forces to create a survey that targets patient reception of bacteria-mediated treatment and antimicrobial peptides. Columbia iGEM created the backbone of the survey and Stony Brook iGEM revised it and added their own section. Stony Brook iGEM collected most of the survey participant data. We aimed for a stratified random sample of participants, specifically targeting the younger generation as well as middle-aged and older people. The statistical analysis of the results of this survey will provide insight upon patient reception of the treatments developed by the two teams.
 +
</td>
 +
          </tr>
 +
 +
 
         </tbody>
 
         </tbody>
 
       </table>
 
       </table>

Revision as of 02:59, 31 October 2017

Collaborations

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Sint, explicabo dolores ipsam aliquam inventore corrupti.

University Type of Collaboration Details
Boston University Survey We completed a survey on microfluidics to help Boston University gather data for their project.
Düsseldorf Cologne Postcards We designed a postcard of our project to help team Düsseldorf Cologne with their goal of disseminating cards to the public with the hope of educating their audience on synthetic biology.
Aristotle University of Thessaloniki Experiment / Modelling / Survey We conducted experiments to data feed their quorum sensing model. OD measurements over 9 and 12 hrs, 10 min intervals, of colonies carrying our quorum sensing plasmid. We also received answers for our surveys concerning bacteria mediated cancer therapies, from both patients and field specialists.
Stony Brook University Survey While new treatments can be very powerful, the ability of treatments to impact patients heavily relies on the willingness of patients to embrace them. To assess how well patients will receive the treatments developed by Columbia iGEM and Stony Brook iGEM, the two teams have joined forces to create a survey that targets patient reception of bacteria-mediated treatment and antimicrobial peptides. Columbia iGEM created the backbone of the survey and Stony Brook iGEM revised it and added their own section. Stony Brook iGEM collected most of the survey participant data. We aimed for a stratified random sample of participants, specifically targeting the younger generation as well as middle-aged and older people. The statistical analysis of the results of this survey will provide insight upon patient reception of the treatments developed by the two teams.